Volpara Health Technologies Ltd (ASX: VHT) Share Price and News





  (20 mins delayed)

52 Week Range


1 Year Return


Volpara Health Technologies Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $291.26 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 254.37 million
Earnings per share -0.036
Dividend per share N/A
Year To Date Return 3.62%
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range


Yesterday's Close

Today's Open

Days Range



Avg. Volume (1 month)


as at 24 Feb 3:44pm

  • Volpara Health Technologies Ltd (ASX: VHT)
    Latest News

    A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs
    Share Gainers

    Why Core Lithium, Regis Resources, Spartan, and Volpara shares are jumping today

    These ASX shares are having incredible days. But why?

    Read more »

    Shot of a young scientist using a digital tablet while working in a lab.
    Healthcare Shares

    ASX healthcare stock Volpara rockets 43% after accepting takeover offer

    This healthcare stock has accepted a ~$300 million takeover offer.

    Read more »


    School-leaver to retiree: ASX stocks I'd buy for each age bracket

    If life is a journey, here are the stocks I'd pick up along the way.

    Read more »

    A mature age woman with a groovy short haircut and glasses, sits at her computer, pen in hand thinking about information she is seeing on the screen.

    I'd invest $10,000 into these excellent ASX shares for the long-term

    These stocks are very high-quality ideas.

    Read more »

    An alligator fights with a businesswoman in an office.
    Cheap Shares

    I'd start snapping up quality cheap ASX shares before stock prices start rising!

    I think it’s time to be greedy with these ASX shares.

    Read more »

    A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
    Healthcare Shares

    Why is the Volpara share price rocketing 13% today?

    This health technology share is catching the eye with a very strong gain on Tuesday.

    Read more »

    a man sits back from his laptop computer with both hands behind his head feeling happy to see the Brambles share price moving significantly higher today

    ASX wealth: How I'd aim to turn $50,000 into $500,000 for retirement

    Here’s how I’d try to build my portfolio.

    Read more »

    a mature but cool older woman holds a watering can and tends to a healthy green plant growing up the wall in her house.
    Growth Shares

    2 ASX growth shares I'd buy over Nvidia

    I’d rather back these ASX leaders.

    Read more »

    A young boy sits on his dad's shoulders while both flex their muscles.
    Growth Shares

    2 ASX growth shares I rate as buys for their big potential

    These companies are seeing pleasing demand for their technology offerings.

    Read more »

    A woman stares directly ahead wearing diamond earrings, diamond necklace and diamond bracelet. as the Lovisa share price rises
    Growth Shares

    3 ASX growth shares I'd buy with $1,500 right now

    I’m backing these stocks to significantly grow their profit in the next few years.

    Read more »

    Kid putting a coin in a piggy bank.
    Small Cap Shares

    Why I'd buy small-cap shares over ASX blue chips at every chance

    From small things big things grow.

    Read more »

    A young man wearing glasses writes down his stock picks in his living room.
    How to invest

    How I'd build a 'best ASX stocks to buy right now' list

    When looking for opportunities, this is how I’d go about it.

    Read more »

    Frequently Asked Questions

    No, the ASX healthcare share has not yet paid any dividends.

    Volpara listed on 27 April 2016.

    VHT ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

    About Volpara Health Technologies Ltd

    Volpara Health Technologies Ltd (ASX: VHT) is a small but growing research, development, and manufacturing company that provides breast screening technology and risk analysis for patients and medical professionals.

    Volpara’s artificial intelligence-powered software for early detection of breast cancer is used by more than 2,000 facilities and more than 5,600 mammography technologists, impacting nearly 15 million patients globally. Volpara is based in Wellington, New Zealand, and also has a US office in Seattle.

    VHT Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    03 May 2024 $1.15 $0.01 0.88% 1,347,641 $1.15 $1.15 $1.14
    02 May 2024 $1.14 $0.00 0.00% 999,903 $1.15 $1.15 $1.14
    01 May 2024 $1.14 $-0.01 -0.87% 23,096 $1.14 $1.15 $1.14
    30 Apr 2024 $1.15 $0.01 0.88% 4,997,892 $1.14 $1.15 $1.14
    29 Apr 2024 $1.14 $0.00 0.00% 59,122 $1.14 $1.15 $1.14
    26 Apr 2024 $1.14 $0.00 0.00% 1,436,577 $1.14 $1.15 $1.14
    24 Apr 2024 $1.14 $0.00 0.00% 1,385,421 $1.14 $1.15 $1.14
    23 Apr 2024 $1.14 $0.00 0.00% 70,916 $1.14 $1.15 $1.14

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    17 Aug 2023 Mark Bouw Issued 450,000 $585,000
    Issue of options.
    02 Jun 2023 Teri Thomas Sell 3,577 $2,546
    On-market trade.
    01 Jun 2023 Teri Thomas Exercise 75,280 $57,213
    Conversion of securities. 150,561 RSUs, As per announcement on 02-06-2023
    01 Jun 2023 Teri Thomas Buy 75,280 $57,213
    Conversion of securities. As per announcement on 02-06-2023

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Roger Allen Non-Executive Director Jun 2010
    Roger was Volpara s first major investor, joined the Board
    prior to FDA approval in June 2010, and was Chair from
    October 2015 to March 2019.
    Roger is a well-known entrepreneur, venture capitalist (VC),
    and social impact investor and philanthropist whose global
    career has spanned over 50 years. He helped pioneer the
    Australian technology industry through the Computer
    Power Group, one of the first Australian-founded tech
    companies to scale globally and subsequently IPO in 1987,
    turning over approx. $1B in today s currency. Following
    the companys acquisition in 1995, he cofounded Allen &
    Buckeridge Pty Ltd, one of the first early-stage VC firms.
    Mr John Dimitrious Pavlidis Non-Executive Director Feb 2015
    John Pavlidis joined the VHT board in February
    2015 and has more than 30 years of experience
    as a senior healthcare executive, CEO, or
    company director in the areas of womens health,
    diagnostic imaging, image analysis and artificial
    intelligence, and cardiovascular therapies.
    Mr Paul Reid Non-Executive DirectorNon-Executive Chairman Mar 2018
    Paul joined the Board in March 2018 and brings extensive
    commercial experience gained across a range of
    technology/Software as a Service businesses.
    He was the founding CEO and Chairman of Figured
    Limited, a fintech SaaS company that provides
    management accounting software to farmers in the
    United States, the United Kingdom ,
    Australia, and New Zealand . Figured was the
    NZ Hi-Tech Startup Company of the Year in 2016 and
    has grown at an incredible pace, funded by private,
    corporate and venture capital (VC) investors.
    Ms Karin Lindgren Non-Executive Director Jan 2020
    Karin joined the Board in 2020. She brings over 35 years
    experience in health information technology as a senior
    technology executive and law firm partner. As one of
    the earliest healthcare technology lawyers in the USA,
    Karin has an in-depth knowledge of data governance,
    data privacy, SaaS, and US healthcare, and has extensive
    professional networks across the IT landscape
    Ms Ann Custin Non-Executive Director Sep 2021
    network of industry contacts from an extensive
    career in healthcare across Europe, the Americas,
    and Asia. Her most recent executive role was with
    Siemens Healthineers, where she served as both CFO
    and board director of Siemens Medical Solutions.
    Prior to this role, Ann served as Chief Operating
    and Financial Officer of Scientx and President &
    CEO of USA Draeger Medical Systems, Inc.
    Ms Teri Thomas Chief Executive OfficerManaging Director Apr 2022
    Teri joined the Board in October 2022. She has a
    long history of executive management in healthcare
    IT ranging from strategy and operations to running
    global sales and marketing teams. This includes a
    20-year career at Epic, a global leader in electronic
    health record (EHR) systems and other software
    solutions used by hospitals and healthcare
    organisations in the United States and internationally
    Mr Mark Bouw Non-Executive Director Jan 2023
    Mr Bouw is a experienced senior healthcare CEO .He is a visiting consultant at Stanford University Graduate Business School Seed Program in the United States and is a visiting mentor for Stanfords Ignite program.
    Mr Craig Hadfield Chief Financial OfficerJoint Company Secretary Mar 2017
    Mr Fred Struve General CounselJoint Company Secretary Oct 2022
    Craig Hadfield Chief Financial OfficerJoint Company Secretary
    Fred Struve General CounselJoint Company Secretary

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    No Top 20 27,534,688 10.84%
    Patagorang Pty Ltd 18,467,848 7.27%
    Ralph Highnam And Kyc Trustees 106 Limited <Highnam Share A/C> 16,213,561 6.38%
    Citicorp Nominees Pty Limited 11,830,450 4.66%
    HSBC Custody Nominees (Australia) Limited 8,187,911 3.22%
    Custodial Services Limited <Beneficiaries Holding A/C> 8,154,911 3.21%
    Bnp Paribas Noms (Nz) Ltd <Drp> 7,061,556 2.78%
    Prof Sir Michael Brady 6,619,075 2.61%
    Mr Marcus Sarner 5,980,404 2.35%
    National Nominees Limited 4,728,818 1.86%
    BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient 4,420,193 1.74%
    Sir Martin Francis Wood 3,004,655 1.18%
    Lady Kathleen Audrey Wood 3,004,654 1.18%
    BNP Paribas Noms Pty Ltd <Drp> 2,527,511 0.99%
    Prof Martin Yaffe 1,966,483 0.77%
    Mr John Anthony Dell 1,928,864 0.76%
    BNP Paribas Nominees Pty Ltd HUB24 Custodial Serv Limited 1,917,409 0.75%
    Prof Nico Karssemeijer 1,806,806 0.71%
    Melbourne Securities Corporation Limited <Horizon 3 Biotech Fund A/C> 1,519,964 0.60%
    RX HOUSE TRUST PTY LTD 880,758 0.35%